Browsing by Author "Yalcin, K."
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Publication Long-term follow-up after peg-ifna2a-based therapy of chronic hepatitis delta(Elsevier Science Bv, 2013-04-01) Heidrich, B.; Yurdaydin, C.; Kabacam, G.; Zachou, K.; Bremer, B.; Dalekos, G. N.; Erhardt, A.; Cakaloglu, Y.; Yalcin, K.; Zeuzem, S.; Bock, T.; Idilman, R.; Manns, M. P.; Wedemeyer, H.; Gurel, Selim; GÜREL, SELİM; Bursa Uludağ Üniversitesi/Tıp Fakültesi; 0000-0003-2906-0480; HLH-8209-2023Publication Prolonged therapy of hepatitis delta for 96 weeks with pegylated-interferon-α-2a plus tenofovir or placebo does not prevent hdv rna relapse after treatment: The hidit-2 study(Elsevier, 2014-04-01) Wedemeyer, H.; Yurdaydin, C.; Ernst, S.; Caruntu, F. A.; Curescu, M. G.; Yalcin, K.; Akarca, U. S.; Gürel, Selim; Zeuzem, S.; Erhardt, A.; Lueth, S.; Papatheodoridis, G. V.; Keskin, O.; Port, K.; Radu, M.; Celen, M. K.; Ildeman, R.; Stift, J.; Heidrich, B.; Mederacke, I.; Hardtke, S.; Koch, A.; Dienes, H. P.; Manns, M. P.; HIDIT-2 Study Grp; GÜREL, SELİM; Uludağ Üniversitesi/Tıp Fakültesi; HLH-8209-2023